February 19, 2026 · Form 4 insider transaction
Sachdev Amit sold 920 shares of Vertex Pharmaceuticals Incorporated at $463.91 per share, a transaction worth $426.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025.; Open market sales reported on this line occurred at a weighted average price of $463.91 (range $463.44 to $464.28).; Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.